GlassScriptPhysician profile
Eric C Umbreit
NPI 1538363577
$2,590.56
in general payments reported to CMS, 2019-2025
9 companies · $1,927 in 2025
The $1,927 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2021: $130 · 2023: $39.42 · 2024: $222 · 2025: $1,927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,232 · Food and Beverage: $956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,232.28 |
| Food and Beverage | $955.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,833.16 | 2025 | |
| Biotissue Holdings INC. | $272.50 | 2019-2024 | |
| Boston Scientific Corporation | $109.96 | 2023-2024 | Ams 800 Artificial Urinary Sphincter |
| Ethicon US, LLC | $108.34 | 2019 | |
| Astellas Pharma US INC | $91.26 | 2021 | |
| Urogen Pharma, INC. | $64.58 | 2025 | |
| Merck Sharp & Dohme LLC | $43.50 | 2019 | |
| Laborie Medical Technologies Corp. | $38.42 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $28.84 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Umbreit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.